| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1995-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc8a39a2e4716931d2987bcc76285ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d7c883e1562bfcbf17f629c93d42f7 |
| publicationDate |
1999-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5861373-A |
| titleOfInvention |
IGF-1 to improve the neural condition |
| abstract |
A method of treating injuries to or diseases of the central nervous system that predominantly affects glia and/or non-cholinergic neuronal cells characterized in that it comprises the step of increasing the active concentration(s) of insulin-like growth factor 1 and/or analogues thereof in the central nervous system of the patient. The present invention also provides therapeutic compositions comprising insulin-like growth factor 1 and/or analogues thereof for administration to a patient at or following a neural insult, which compositions are useful in minimizing damage to the central nervous system that would otherwise occur following the insult. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011076702-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43982-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006251649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006154865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006211606-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010121036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006105946-A9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5965531-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8476232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007298009-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7605177-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008039390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012177630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011045510-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011183903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9724425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009297573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6693076-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6984405-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8552158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007004641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009253628-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7041314-B2 |
| priorityDate |
1991-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |